Public knowledge of ipecac syrup in themanagement of accidental poisonings - 07/10/17
Doi : 10.1016/S0022-3476(67)80020-9
Joel J. Alpert, M.D. a, b, * : Executive Secretary, Melvin D. Levine, M.D. a, b, John Kosa, Ph.D. a, b
a Boston Poison Information Center;Child Health Division, Children's Hospital Medical Center, Boston, Mass. USA
b Family Health Care Program, Departments of Pediatrics, Harvard Medical School, Boston, Mass., USA
Abstract |
Information given during a Poison Prevention Week increased the knowledge of and the willingness to use ipecac syrup but not the actual possession of the drug. Distribution by physicians significantly increased possession. There is need for the development of programs which will secure the interest and participation of the practicing physician.
Le texte complet de cet article est disponible en PDF.| * | Supported in part by grants(H-74 and H-118) from the United States Children's Bureau, Social Security Administration, Department of Health, Education, and Welfare. |
| † | The field work relating to the telephone samplewas conducted by Community Research Project of Metropolitan Boston under the direction of Morris Axelrod, Ph.D., and Floyd J. Fowler, Jr., Ph.D. |
© 1967
Publié par Elsevier Masson SAS.
Vol 71 - N° 6
P. 890-894 - décembre 1967 Retour au numéro
Article précédent
- Oral administration of n-acetyl cysteine in the prophylaxis of “meconium ileus equivalent”
- Clinton B. Lillibridge, Jack M. Docter, Shmuel Eidelman
- Detailing ipecac : Report of the committee on poison control, rocky mountainpediatric society
- Ray Helfer, Gordon Fleischaker, Leland Huhn, Richard Moore, Daniel Plunket, Daniel Teitelbaum
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?